002294.SZ
信立泰
SZSE · Healthcare · C 制造业 · CN
CNY 31.62
−3.24%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 4.5B | 4.4B | 4.0B | 3.4B | 3.5B |
| Cost of Revenue | 1.1B | 1.1B | 1.1B | 1.1B | 993.6M |
| Gross Profit | 3.4B | 3.3B | 2.9B | 2.3B | 2.5B |
| Operating Expenses | |||||
| R&D Expense | 562.5M | 539.3M | 421.2M | 409.2M | 533.7M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 261.7M | 268.5M | 271.9M | 286.6M | 237.6M |
| Selling & Marketing Expense | 1.8B | 1.8B | 1.5B | 1.0B | 1.1B |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 2.7B | 2.6B | 2.2B | 1.7B | 1.8B |
| Cost and Expenses | 3.9B | 3.7B | 3.3B | 2.8B | 2.8B |
| Operating Income (EBIT) | 709.1M | 682.9M | 646.3M | 656.0M | 727.4M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 683.4M | 655.9M | 632.5M | 641.8M | 713.7M |
| Income Tax Expense | 7.7M | 3.1M | 27.4M | 60.9M | 79.4M |
| Bottom Line | |||||
| Net Income | 676.4M | 651.5M | 601.6M | 580.1M | 637.1M |
| Earnings from Cont. Ops | 675.8M | 652.8M | 605.2M | 580.8M | 634.4M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 676.4M | 651.5M | 601.6M | 580.1M | 637.1M |
| Per Share | |||||
| Basic EPS | CN¥0.61 | CN¥0.58 | CN¥0.54 | CN¥0.52 | CN¥0.58 |
| Diluted EPS | CN¥0.61 | CN¥0.58 | CN¥0.54 | CN¥0.52 | CN¥0.58 |
| Revenue Per Share | CN¥4.01 | CN¥3.87 | CN¥3.60 | CN¥3.02 | CN¥3.17 |
| Shares | |||||
| Basic Shares Outstanding | 1.1B | 1.1B | 1.1B | 1.1B | 1.1B |
| Diluted Shares Outstanding | 1.1B | 1.1B | 1.1B | 1.1B | 1.1B |
| Profitability Metrics | |||||
| EBITDA | — | 1.1B | 1.0B | 1.0B | 1.1B |
| D&A | — | 422.8M | 395.2M | 357.2M | 337.0M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026